Parathyroid Carcinoma in the Setting of Tertiary Hyperparathyroidism: Case Report and Review of the Literature.


Journal

Case reports in endocrinology
ISSN: 2090-6501
Titre abrégé: Case Rep Endocrinol
Pays: United States
ID NLM: 101576457

Informations de publication

Date de publication:
2020
Historique:
received: 07 02 2020
revised: 21 11 2020
accepted: 25 11 2020
entrez: 21 12 2020
pubmed: 22 12 2020
medline: 22 12 2020
Statut: epublish

Résumé

Parathyroid carcinoma is one of the rarest cancers in normal population, and it is extremely uncommon in the setting of tertiary hyperparathyroidism. Indeed, only 24 cases have been reported in the literature. To date, radical surgery represents the mainstay of treatment, with a five- and ten-year survival rates overall acceptable.

Identifiants

pubmed: 33343947
doi: 10.1155/2020/5710468
pmc: PMC7725582
doi:

Types de publication

Case Reports

Langues

eng

Pagination

5710468

Informations de copyright

Copyright © 2020 Federico Cappellacci et al.

Déclaration de conflit d'intérêts

The authors declare that there are no conflicts of interest regarding the publication of this article.

Références

Tumori. 2005 Nov-Dec;91(6):558-62
pubmed: 16457158
Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):877-889
pubmed: 30551989
Transplant Proc. 2007 Jul-Aug;39(6):1775-8
pubmed: 17692609
Int J Surg Case Rep. 2019;65:322-324
pubmed: 31770707
Endocr Pathol. 2014 Dec;25(4):433-5
pubmed: 25284121
Mod Pathol. 2019 Jul;32(8):1082-1094
pubmed: 30923346
Nat Genet. 2002 Dec;32(4):676-80
pubmed: 12434154
Int Surg. 2002 Oct-Dec;87(4):226-32
pubmed: 12575805
Minerva Chir. 2012 Aug;67(4):337-42
pubmed: 23022758
N Engl J Med. 2003 Oct 30;349(18):1722-9
pubmed: 14585940
Surgery. 1996 Nov;120(5):897-901
pubmed: 8909528
Endocr Pathol. 2018 Jun;29(2):113-129
pubmed: 29626276
J Am Coll Surg. 2004 Aug;199(2):312-9
pubmed: 15275889
Asian J Surg. 2016 Oct;39(4):255-9
pubmed: 27664600
J Am Soc Nephrol. 2000 Jun;11(6):1141-52
pubmed: 10820180
BMC Endocr Disord. 2019 May 29;19(Suppl 1):46
pubmed: 31142320
J Endocrinol Invest. 2016 Jun;39(6):595-606
pubmed: 27001435
Clin Med Insights Endocrinol Diabetes. 2013 Oct 23;6:63-7
pubmed: 24250241
Minerva Endocrinol. 2018 Jun;43(2):144-155
pubmed: 28949121
Front Horm Res. 2019;51:63-76
pubmed: 30641523
Am J Otolaryngol. 2017 Sep - Oct;38(5):630-635
pubmed: 28735762
J Clin Pathol. 2015 Oct;68(10):771-87
pubmed: 26163537
J Laryngol Otol. 2004 Feb;118(2):162-4
pubmed: 14979960
Am J Surg Pathol. 2006 Sep;30(9):1140-9
pubmed: 16931959
Surg J (N Y). 2017 Feb 28;3(1):e23-e24
pubmed: 28825015
Cancer. 1999 Aug 1;86(3):538-44
pubmed: 10430265
Langenbecks Arch Surg. 2008 Sep;393(5):639-45
pubmed: 18651167
Neuroimaging Clin N Am. 2008 Aug;18(3):537-49, ix
pubmed: 18656034
Oral Oncol. 2018 Nov;86:314-315
pubmed: 30274770
Int J Surg. 2017 May;41 Suppl 1:S26-S33
pubmed: 28506410
BMC Surg. 2013 Sep 18;13:36
pubmed: 24044556

Auteurs

Federico Cappellacci (F)

Department of Surgical Sciences, University of Cagliari, "Policlinico Universitario Duilio Casula", 09042 Monserrato, Italy.

Fabio Medas (F)

Department of Surgical Sciences, University of Cagliari, "Policlinico Universitario Duilio Casula", 09042 Monserrato, Italy.

Gian Luigi Canu (GL)

Department of Surgical Sciences, University of Cagliari, "Policlinico Universitario Duilio Casula", 09042 Monserrato, Italy.

Maria Letizia Lai (ML)

Department of Cytomorphology, University of Cagliari, Cagliari, Italy.

Giovanni Conzo (G)

Division of Medical Oncology, Department of Internal and Experimental Medicine "F. Magrassi", School of Medicine, University of Campania "Luigi Vanvitelli", Cagliari, Italy.

Enrico Erdas (E)

Department of Surgical Sciences, University of Cagliari, "Policlinico Universitario Duilio Casula", 09042 Monserrato, Italy.

Pietro Giorgio Calò (PG)

Department of Surgical Sciences, University of Cagliari, "Policlinico Universitario Duilio Casula", 09042 Monserrato, Italy.

Classifications MeSH